boxed warning
WARNING: NOT FOR USE IN NEONATES.
BACTERIOSTATIC SODIUM CHLORIDE
openFDA label record#
This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.
Verified complete openFDA source JSON
- Brand name
- BACTERIOSTATIC SODIUM CHLORIDE
- Generic name
- SODIUM CHLORIDE
- Manufacturer
- Medical Purchasing Solutions, LLC
- Product type
- HUMAN PRESCRIPTION DRUG
- SPL set ID
- 8a0d24a9-d02a-0379-e053-2a95a90af712
- SPL ID
- fc5fb080-bb9e-3283-e053-6394a90aabfb
- Version
- 2
- Effective date
- 2023-05-23
- Source export date
- 2026-08-01
- Source partition
- 5
- Source file
- https://download.open.fda.gov/drug/label/drug-label-0005-of-0014.json.zip
- Source object key
- raw/openfda/drug-label/2026-08-01/5a565ce64c898c83223b815b9579cd46fb0c6d54977c3cace2133e40124f7fbb/drug-label-0005-of-0014.json.zip
- Source manifest SHA-256
- bdd1454d0606b622b70458a306b8a10d8a8787db06fd9f46e69c7f7a4524b630
- Import run
- 20260801T225920Z
- Imported at
- 2026-08-01 23:09:50
| Harmonized routes |
|---|
| INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS |
Harmonized identifier links#
Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.
| Type | Scope | Identifier | Source field |
|---|---|---|---|
| application applno | NDA | 018800 | derived:openfda.application_number |
| application number | NDA018800 | openfda.application_number | |
| brand name | BACTERIOSTATIC SODIUM CHLORIDE | openfda.brand_name | |
| generic name | SODIUM CHLORIDE | openfda.generic_name | |
| manufacturer name | Medical Purchasing Solutions, LLC | openfda.manufacturer_name | |
| ndc | package | 71872-7083-1 | openfda.package_ndc |
| ndc | product | 71872-7083 | openfda.product_ndc |
| ndc11 | package | 71872708301 | derived:openfda.package_ndc |
| rxcui | 313002 | openfda.rxcui | |
| spl id | fc5fb080-bb9e-3283-e053-6394a90aabfb | id | |
| spl set id | 8a0d24a9-d02a-0379-e053-2a95a90af712 | set_id | |
| unii | 451W47IQ8X | openfda.unii |
Boxed warning cross-check#
openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
Warnings cross-check#
openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
warnings
WARNINGS Benzyl alcohol, a preservative in Bacteriostatic Sodium Chloride Injection, USP has been associated with toxicity in neonates. Data are unavailable on the toxicity of other preservatives in this age group. Preservative-free Sodium Chloride Injection should be used for flushing intravascular catheters. Where a sodium chloride solution is required for preparing or diluting medications for use in neonates, only preservative-free Sodium Chloride Injection should be used.
Adverse reactions cross-check#
openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
adverse reactions
ADVERSE REACTIONS Reactions which may occur because of this solution, added drugs or the technique of reconstitution or administration include febrile response, local tenderness, abscess, tissue necrosis or infection at the site of injection, venous thrombosis or phlebitis extending from the site of injection and extravasation. If an adverse reaction does occur, discontinue the infusion, evaluate the patient, institute appropriate countermeasures, and if possible, retrieve and save the remainder of the unused vehicle for examination. Although adverse reactions to intravenous, intramuscular or subcutaneous injection of 0.9% benzyl alcohol are not known to occur in man, experimental studies of small volume parenteral preparations containing 0.9% benzyl alcohol in several species of animals have indicated that an estimated intravenous dose up to 30 mL may be safely given to an adult without toxic effects. Administration of an estimated 9 mL to a 6 kg neonate or infant is potentially capable of producing blood pressure changes.